VCAM1 and atherosclerosis: The novelty of these antibody candidates—particularly regarding their binding activity to VCAM-1 domains other than domains 1 and 4—highlights the importance of antibody discovery technology for discovering and identifying new molecular mechanisms for combatting multifactorial disease pathologies such as atherosclerosis.